Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcellx, Inc. - Common Stock (NQ:ACLX)

114.51 -0.26 (-0.23%)
Streaming Delayed Price Updated: 11:47 AM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 487,229
Open 114.69
Bid (Size) 114.49 (400)
Ask (Size) 114.51 (300)
Prev. Close 114.77
Today's Range 114.48 - 114.74
52wk Range 47.86 - 114.91
Shares Outstanding 48,358,981
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead program advancing in clinical trials for breast cancer. 
Via The Motley Fool
News headline image
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic... 
Via MarketMinute
Topics Artificial Intelligence Economy Workforce

Performance

YTD
+80.8%
+80.8%
1 Month
+78.6%
+78.6%
3 Month
+75.7%
+75.7%
6 Month
+46.4%
+46.4%
1 Year
+58.0%
+58.0%

More News

Read More
News headline image
Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether SEM, UNF, ACLX, FONR are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
Via The Motley Fool
News headline image
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗
Via The Motley Fool
News headline image
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether BCO, THR, ACLX are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Arcellx President Sells $10 Million Worth of Shares After Acquisition Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcellx President Sells $10M Worth of Shares After Acquisition Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Halper Sadeh LLC is Investigating Whether ACLX, EHAB, VRE are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
From Kahn Swick & Foti, LLC
Via Business Wire
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Here are the top movers in Monday's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
ACLX Stock Alert: Halper Sadeh LLC is Investigating Whether Arcellx, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
From Arcellx, Inc.
Via Business Wire
News headline image
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
Via Finterra
Topics Economy Intellectual Property
News headline image
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
From Arcellx, Inc.
Via Business Wire

Frequently Asked Questions

Is Arcellx, Inc. - Common Stock publicly traded?
Yes, Arcellx, Inc. - Common Stock is publicly traded.
What exchange does Arcellx, Inc. - Common Stock trade on?
Arcellx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arcellx, Inc. - Common Stock?
The ticker symbol for Arcellx, Inc. - Common Stock is ACLX on the Nasdaq Stock Market
What is the current price of Arcellx, Inc. - Common Stock?
The current price of Arcellx, Inc. - Common Stock is 114.51
When was Arcellx, Inc. - Common Stock last traded?
The last trade of Arcellx, Inc. - Common Stock was at 03/23/26 11:47 AM ET
What is the market capitalization of Arcellx, Inc. - Common Stock?
The market capitalization of Arcellx, Inc. - Common Stock is 5.54B
How many shares of Arcellx, Inc. - Common Stock are outstanding?
Arcellx, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.